La comunicación farmacéutica en la normativa española: evolución y desafíos de la sociedad digital.
- Published in:
- Observatorio (OBS*), 2025, v. 19, n. 1, p. 160, doi. 10.15847/obsobs19120252597
- By:
- Publication type:
- Article
Works matching DE "DRUG advertising"
Results: 585
1
2
What Your Patients Need to Know about Pain.
- Published in:
- Nutritional Perspectives: Journal of the Council on Nutrition, 2007, v. 30, n. 2, p. 5
- By:
- Publication type:
- Article
3
Role of active surveillance in improving hospital adverse drug event monitoring.
- Published in:
- Indian Journal of Pharmacology, 2006, v. 38, n. 5, p. 363, doi. 10.4103/0253-7613.27709
- By:
- Publication type:
- Article
4
Suffering, Pharmaceutical Advertising, and the Face of Mental Illness.
- Published in:
- 2006
- By:
- Publication type:
- Essay
5
An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
Time to Ban Direct-to-Consumer Prescription Drug Marketing.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
7
Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer Advertising.
- Published in:
- Annals of Family Medicine, 2007, v. 5, n. 1, p. 6, doi. 10.1370/afm.611
- By:
- Publication type:
- Article
8
What's ahead for the FDA?
- Published in:
- Patient Care (Print), 2006, v. 40, n. 12, p. 9
- Publication type:
- Article
9
Iustitias vestras iudicabo – European Commision’s action against Poland over the prohibition of pharmacy advertising.
- Published in:
- Eastern European Journal of Transnational Relations (EEJTR), 2023, v. 7, n. 1, p. 129, doi. 10.15290/eejtr.2023.07.01.12
- By:
- Publication type:
- Article
10
"Give Me Happiness" or "Take Away My Pain": Explaining consumer responses to prescription drug advertising.
- Published in:
- Cogent Business & Management, 2015, v. 2, n. 1, p. 1, doi. 10.1080/23311975.2015.1024926
- By:
- Publication type:
- Article
11
The Viagra Ad Venture: Masculinity, Media, and the Performance of Sexual Health.
- Published in:
- 2005
- By:
- Publication type:
- Book Review
12
THE INFORMATION UTILITY OF DTC PRESCRIPTION DRUG ADVERTISING.
- Published in:
- Journalism & Mass Communication Quarterly, 2004, v. 81, n. 4, p. 788, doi. 10.1177/107769900408100405
- By:
- Publication type:
- Article
13
Correction of Overstatement and Omission in Direct-to-Consumer Prescription Drug Advertising.
- Published in:
- Journal of Communication, 2015, v. 65, n. 4, p. 596, doi. 10.1111/jcom.12167
- By:
- Publication type:
- Article
14
Clinical Alert Update: Is Hyaluronidase Available?
- Published in:
- ONS News, 2001, v. 16, n. 9, p. 3
- Publication type:
- Article
15
Quality and content of dental practice websites.
- Published in:
- British Dental Journal, 2011, v. 210, n. 7, p. E11, doi. 10.1038/sj.bdj.2011.242
- By:
- Publication type:
- Article
16
Ethical and Scientific Criteria for Pharmaceutical Advertising.
- Published in:
- Clinical Pediatrics, 1968, v. 7, n. 11, p. 694
- Publication type:
- Article
17
Reflection.
- Published in:
- Clinical Pediatrics, 1967, v. 6, n. 1, p. 22A
- Publication type:
- Article
18
Gender and images of heart disease in Scandinavian drug advertising.
- Published in:
- Scandinavian Journal of Public Health, 2007, v. 35, n. 6, p. 585, doi. 10.1080/14034940701349233
- By:
- Publication type:
- Article
19
Uma solução mágica para a dor de viver: reflexões psicanalíticas sobre o consumo de analgésicos.
- Published in:
- Revista Latinoamericana de Psicopatologia Fundamental, 2013, v. 16, n. 2, p. 318, doi. 10.1590/S1415-47142013000200009
- By:
- Publication type:
- Article
20
Enforcement of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, in the State of Andhra Pradesh: situational analysis and lessons learnt.
- Published in:
- Journal of Pharmaceutical Health Services Research, 2018, v. 9, n. 1, p. 47, doi. 10.1111/jphs.12207
- By:
- Publication type:
- Article
21
Exposure to Marijuana Marketing After Legalization of Retail Sales: Oregonians' Experiences, 2015-2016.
- Published in:
- American Journal of Public Health, 2018, v. 108, n. 1, p. 120, doi. 10.2105/AJPH.2017.304136
- By:
- Publication type:
- Article
22
FDA Sounds Alert on Anemia Drugs.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 17, p. 1868, doi. 10.1001/jama.297.17.1868
- By:
- Publication type:
- Article
23
Researchers Critical of TV Drug Ads.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 9, p. 939, doi. 10.1001/jama.297.9.939
- By:
- Publication type:
- Article
24
THERAPEUTIC DECADENCE IN BRITAIN.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 294, n. 18, p. 2371, doi. 10.1001/jama.294.18.2371
- By:
- Publication type:
- Article
25
‘The Strophanthin question’: early scientific marketing of cardiac drugs in two national markets (France and Germany, 1900–1930).
- Published in:
- History & Technology, 2013, v. 29, n. 2, p. 135, doi. 10.1080/07341512.2013.833039
- By:
- Publication type:
- Article
26
From Propaganda to scientific marketing: Schering, cortisone, and the construction of drug markets.
- Published in:
- History & Technology, 2013, v. 29, n. 2, p. 188, doi. 10.1080/07341512.2013.828510
- By:
- Publication type:
- Article
27
Standardizing selling. Pharmaceutical marketing, the pharmaceutical company and the marketing expert (1900–1980).
- Published in:
- History & Technology, 2013, v. 29, n. 2, p. 169, doi. 10.1080/07341512.2013.827015
- By:
- Publication type:
- Article
28
Pharmaceutical firms and the construction of drug markets: from branding to scientific marketing.
- Published in:
- History & Technology, 2013, v. 29, n. 2, p. 105, doi. 10.1080/07341512.2013.828867
- By:
- Publication type:
- Article
29
Barriers and Strategies Related to Qualitative Research on Genetic Ancestry Testing in Indigenous Communities.
- Published in:
- Journal of Empirical Research on Human Research Ethics, 2017, v. 12, n. 3, p. 169, doi. 10.1177/1556264617704542
- By:
- Publication type:
- Article
30
Specificity of Pharmaceutical Marketing and requirements for prescription drugs' promotion in Bosnia and Herzegovina.
- Published in:
- Folia Medica Facultatis Medicinae Universitatis Saraeviensis, 2010, v. 45, n. 1, p. 29
- By:
- Publication type:
- Article
31
Understanding and preventing the advertisement and sale of illicit drugs to young people through social media: A multidisciplinary scoping review.
- Published in:
- Drug & Alcohol Review, 2024, v. 43, n. 1, p. 56, doi. 10.1111/dar.13716
- By:
- Publication type:
- Article
32
Phallic metaphors and metonyms: Emerging meanings of Viagra and masculinity in news media.
- Published in:
- Sexualities, 2025, v. 28, n. 3, p. 1347, doi. 10.1177/13634607241261842
- By:
- Publication type:
- Article
33
GIVING PERSONAL INJURY ATTORNEYS WHO RUN MISLEADING DRUG ADS A DOSE OF THEIR OWN MEDICINE.
- Published in:
- University of Illinois Law Review, 2019, v. 2019, n. 2, p. 701
- By:
- Publication type:
- Article
34
HAVE YOU Read?
- Published in:
- AUANews, 2016, v. 21, n. 2, p. 16
- By:
- Publication type:
- Article
35
Regulating pharmaceutical advertising: What will work?
- Published in:
- Canadian Medical Association Journal (CMAJ), 1997, v. 156, n. 3, p. 359
- By:
- Publication type:
- Article
36
Enforcement of codes governing pharmaceutical promotion: What happens when companies breach...
- Published in:
- Canadian Medical Association Journal (CMAJ), 1997, v. 156, n. 3, p. 351
- By:
- Publication type:
- Article
37
Competition in prescription drug markets: the roles of trademarks, advertising, and generic names.
- Published in:
- European Journal of Health Economics, 2013, v. 14, n. 4, p. 667, doi. 10.1007/s10198-012-0414-7
- By:
- Publication type:
- Article
38
Author's Reply.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
39
Advertising in Medical Journals: Should Current Practices Change?
- Published in:
- PLoS Medicine, 2006, v. 3, n. 6, p. e130, doi. 10.1371/journal.pmed.0030130
- By:
- Publication type:
- Article
40
Disease mongering in drug promotion: do governments have a regulatory role?
- Published in:
- 2006
- By:
- Publication type:
- journal article
41
What are the public health effects of direct-to-consumer drug advertising?
- Published in:
- 2006
- By:
- Publication type:
- journal article
42
Should Industry Speak the Loudest in Informing the Public on Medical Matters?
- Published in:
- 2006
- By:
- Publication type:
- Letter
43
Should Industry Speak the Loudest in Informing the Public on Medical Matters?
- Published in:
- 2006
- By:
- Publication type:
- Letter
44
Why Did the FDA Approve These Advertisements?
- Published in:
- 2006
- By:
- Publication type:
- Letter
45
Serotonin and depression: a disconnect between the advertisements and the scientific literature.
- Published in:
- 2005
- By:
- Publication type:
- journal article
46
Promoção e propaganda de medicamentos em ambientes de ensino: elementos para o debate.
- Published in:
- Interface - Comunicação, Saúde, Educação, 2008, v. 12, n. 27, p. 893
- By:
- Publication type:
- Article
47
Revisión de la advertencia acerca de los antidepresivos y la tendencia al suicidio: mostrando la «caja negra» de los análisis estadísticos.
- Published in:
- American Journal of Psychiatry - Edición Española, 2008, v. 11, n. 3, p. 140
- By:
- Publication type:
- Article
48
Learning to maintain a 'proper' relationship with the pharmaceutical industry.
- Published in:
- 2010
- By:
- Publication type:
- Letter
49
Correction to: Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
50
Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs.
- Published in:
- Research Integrity & Peer Review, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41073-021-00111-9
- By:
- Publication type:
- Article